Paydirt
CS
Insider

Catherine A. Sohn

Director · Maze Therapeutics

Catherine A. Sohn (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $1.1M of MAZE (26,920 sh × $39.11, as filed), executed Jan 7. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.1M
shares × price, as filed
Last traded
Jan 7
Filed Jan 8

Median ADV $16.9M across their filed names

Open performance→
Volume by month
$1.1M$526K$0Dec 2024Jun 2025Dec 2025Jun 2026Jan 2026 · sells $1.1M
Buys $0 Sells $1.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
MAZE Maze Therapeutics, Inc. MAZE · 0 buys · 1 sell 1 filing
Recent filings
MAZESALE Maze Therapeutics, Inc. View filing → $1.1M
26,920 sh × $39.11
Exec Jan 7
Filed Jan 8 · 5:30 PM ET